Financial statements Lorega Bio
Balance sheet of Lorega Bio
Company age:
Age:
14 y. 6 m. 30 d.
Share capital:
Share capital:
50 000 PLN
Balance sheet data of LOREGA BIO
|
Year
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|
| Total assets | 8 727 897,56 | 7 963 094,86 | 6 859 536,62 | 10 796 598,07 |
| A. Fixed assets | 8 088 612,30 | 7 041 144,60 | 5 987 058,10 | 6 362 742,92 |
| B. Current assets | 639 285,26 | 921 950,26 | 872 478,52 | 4 433 855,15 |
| C. Share capital contributions (basic funds) | - | - | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | 0,00 | 0,00 |
| Total liabilities | 8 727 897,56 | 7 963 094,86 | 6 859 536,62 | 10 796 598,07 |
| A. Equity | 1 353 488,30 | 2 178 788,35 | 1 585 216,59 | 1 199 125,32 |
| B. Liabilities and provisions for liabilities | 7 374 409,26 | 5 784 306,51 | 5 274 320,03 | 9 597 472,75 |
| I. Long-term liabilities | 4 333 693,59 | 3 559 569,22 | 3 559 569,22 | 3 879 569,22 |
| II. Short-term liabilities | 1 636 923,87 | 1 254 296,83 | 1 178 434,37 | 1 257 972,55 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.